Blog: INSPIRE MEDICAL SYSTEMS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01. Regulation FD Disclosure.

In May and June of 2022, Inspire Medical Systems, Inc. (the “Company”) will be
participating in various meetings with investors and analysts, and a copy of the
Company’s presentation materials being used at these meetings is furnished as
Exhibit 99.1 hereto and is incorporated herein by reference. These presentation
materials are also available on the Investor Relations page of the Company’s
website at https://investors.inspiresleep.com.

The information in this Current Report on Form 8-K (including Exhibit 99.1)
shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of that Section, nor shall it be deemed to be incorporated by
reference into any filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.                                               Description

99.1                       Inspire Medical Systems, Inc. Presentation,     May     2022

104                      Cover Page Interactive Data File - the cover page XBRL tags are embedded
                         within the Inline XBRL document.



                                       2

——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s